What is SYNA's health score?

SYNAPTICS Inc (SYNA) has a TradeApes health score of 49 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SYNA's estimated fair value?

Based on our 5-year discounted cash flow model, SYNAPTICS Inc's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is SYNA undervalued or overvalued?

Our model currently rates SYNA as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for SYNA... Refresh in a moment for the full analysis.

SYNAPTICS Inc (SYNA)

Technology Overvalued low mixed

$141.09

Updated: 2026-06-05

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

40 Weak

Relative Value

50 Mixed

Capital Allocation

40 Weak

Risk

50 Mixed

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.